Variation in FTO (the fat-mass and obesity-associated gene), GLP1R (the GLP-1 receptor gene that every GLP-1 compound targets), MC4R (a melanocortin receptor tied to satiety and energy balance), and TCF7L2 (a transcription factor linked to glucose handling and GLP-1 secretion) describes the metabolic terrain a compound acts on
Availability depends on provider evaluation, state participation, pharmacy requirements, and clinical eligibility
While this is considered off-label use, some patients report improvements in energy, metabolic health, and overall well-being as they work toward their goals, says Dr
The hormone delivers this benefit via several interlocking effects
Noom Med offers multiple medication pathways, including: Every pathway is integrated with Nooms core strength: evidence-based behavior change